The Dry Eye Syndrome Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of dry eye syndrome has seen a significant increase in the past few years. It is projected to expand from $3.92 billion in 2024 to $4.21 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%.
The Dry Eye Syndrome Global Market Report 2025 forecasts that by 2029, the market size for dry eye syndrome will reach $5.63 billion, growing at a compound annual growth rate (CAGR) of 7.5%.
Download Your Free Sample of the 2025 Dry Eye Syndrome Market Report and Uncover Key Trends Now!The key drivers in the dry eye syndrome market are:
• Aging population demographics contributing to higher incidence of dry eye syndrome
• Increasing screen usage causing greater strain on eyes
• Shift in lifestyle habits leading to increased risk factors
• Improved healthcare awareness and accessibility promoting early diagnosis and treatment.
The dry eye syndrome market covered in this report is segmented –
1) By Product: Liquid Drops, Gel, Liquid Wipes, Eye Ointment, Other Products
2) By Treatment: Corticosteroids, Artificial Tears, Oral Omega Supplements, Lubricating Agent, Other Treatments
3) By Disease Type: Evaporative, Aqueous
4) By Distribution Channel: Offline, Online
5) By Application: Hospitals And Clinics, Medical Laboratories, Other Applications
The key trends in the dry eye syndrome market are:
• The adoption of a holistic approach to eye health is a key emerging trend.
• The integration of artificial intelligence in eye care is shaping the market.
• Telemedicine and remote consultations are becoming increasingly popular.
• Personalized medicine approaches, coupled with an increase in awareness and education, are emerging trends.
The major players in the dry eye syndrome market are:
• Allergan plc
• Novartis AG
• Otsuka Pharmaceutical Co
North America was the largest region in the dry eye syndrome market in 2024